Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 14
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,385 | Dovepress* | 7,043+ | 962 | 8,005 | |
PubMed Central* | 1,342 | 463 | 1,805 | ||
Totals | 8,385 | 1,425 | 9,810 | ||
*Since 18 January 2021 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar